Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Depreciation & Amortization (CF) (2016 - 2018)

Historic Depreciation & Amortization (CF) for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to $261000.0.

  • Armata Pharmaceuticals' Depreciation & Amortization (CF) rose 19659.09% to $261000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $1.1 million, marking a year-over-year increase of 21690.96%. This contributed to the annual value of $1.3 million for FY2024, which is 3631.69% up from last year.
  • Armata Pharmaceuticals' Depreciation & Amortization (CF) amounted to $261000.0 in Q4 2018, which was up 19659.09% from $336000.0 recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Depreciation & Amortization (CF) high stood at $401000.0 for Q2 2018, and its period low was -$27000.0 during Q3 2014.
  • In the last 5 years, Armata Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $85000.0 in 2016 and averaged $109700.0.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first crashed by 22857.14% in 2014, then surged by 47037.04% in 2015.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Depreciation & Amortization (CF) stood at $68000.0 in 2014, then rose by 20.59% to $82000.0 in 2015, then grew by 13.41% to $93000.0 in 2016, then dropped by 5.38% to $88000.0 in 2017, then soared by 196.59% to $261000.0 in 2018.
  • Its Depreciation & Amortization (CF) stands at $261000.0 for Q4 2018, versus $336000.0 for Q3 2018 and $401000.0 for Q2 2018.